z-logo
open-access-imgOpen Access
Precision Oncology Strategy in Trastuzumab-Resistant Human Epidermal Growth Factor Receptor 2–Positive Colon Cancer: Case Report of Durable Response to Ado-Trastuzumab Emtansine
Author(s) -
Derrick S. Haslem,
Hanlee P. Ji,
James M. Ford,
Lincoln Nadauld
Publication year - 2017
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.405
H-Index - 22
ISSN - 2473-4284
DOI - 10.1200/po.16.00055
Subject(s) - trastuzumab , trastuzumab emtansine , human epidermal growth factor receptor 2 , oncology , medicine , colorectal cancer , epidermal growth factor receptor , cancer , metastatic breast cancer , cancer research , breast cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom